AVILIVE obtains the novel crystalline form of picoxystrobin patent license from ALBAUGH for strategic collaboration.

Hangzhou,China, July 1st 2026-Zhejiang Avilive is pleased to announce the signing of patent licensing agreement with Albaugh Asia Pacific Limited to license Albaugh’s Patent in China on the Novel Crystalline form of Picoxystrobin, Under the agreement, Avilive enables technical-grade manufacturing and formulation development and producing, and offer the prodcuts to global markets. the patent is valid in China Until 2037-01-18.

浙江埃森化學(xué)有限公司獲美愛保集團啶氧菌酯新型晶型專利授權(quán)以開展戰(zhàn)略合作

2026 年 7 月 1 日，中國東陽 —— 浙江埃森化學(xué)有限公司欣然宣布，已與美愛保集團簽署專利許可協(xié)議，取得美愛保集團在中國擁有的啶氧菌酯新型晶型專利授權(quán)。根據(jù)協(xié)議約定，浙江埃森化學(xué)有限公司可開展該產(chǎn)品原藥生產(chǎn)與制劑研發(fā)生產(chǎn)工作，并面向全球市場供應(yīng)相關(guān)產(chǎn)品。該專利在中國境內(nèi)有效期至 2037 年 1 月 18 日。